Cargando…
The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
The amyloid-β oligomer (AβO) hypothesis was introduced in 1998. It proposed that the brain damage leading to Alzheimer’s disease (AD) was instigated by soluble, ligand-like AβOs. This hypothesis was based on the discovery that fibril-free synthetic preparations of AβOs were potent CNS neurotoxins th...
Autores principales: | Cline, Erika N., Bicca, Maíra Assunção, Viola, Kirsten L., Klein, William L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004937/ https://www.ncbi.nlm.nih.gov/pubmed/29843241 http://dx.doi.org/10.3233/JAD-179941 |
Ejemplares similares
-
ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease
por: Krafft, Grant A., et al.
Publicado: (2022) -
The Therapeutic and Diagnostic Potential of Amyloid β Oligomers Selective Antibodies to Treat Alzheimer’s Disease
por: Viola, Kirsten L., et al.
Publicado: (2022) -
An Essential Role for Alzheimer’s-Linked Amyloid Beta Oligomers in Neurodevelopment: Transient Expression of Multiple Proteoforms during Retina Histogenesis
por: Bartley, Samuel C., et al.
Publicado: (2022) -
Elucidating Molecular Mass and Shape of a Neurotoxic
Aβ Oligomer
por: Sebollela, Adriano, et al.
Publicado: (2014) -
Alzheimer’s Toxic Amyloid Beta Oligomers: Unwelcome Visitors to the Na/K ATPase alpha3 Docking Station
por: DiChiara, Thomas, et al.
Publicado: (2017)